Keverprazan-amoxicillin dual therapy shows non-inferior H. pylori eradication versus esomeprazole-amoxicillin
New drug shows promise for treating H. pylori infections
This prospective, multicenter randomized controlled trial in 264 treatment-naive adults with H. pylori infection found that 14-day keverpraz…
A new treatment combination showed higher success rates at clearing H. pylori bacteria compared to a standard medication.
Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children
Trial shows oral antibiotics work for children with severe pneumonia
This randomized controlled trial of 1,101 children with severe community-acquired pneumonia in sub-Saharan Africa found that step-down oral …
A large trial in Africa found that switching children from IV to oral antibiotics for pneumonia is as safe and effective as staying on IV tr…
Tegoprazan-amoxicillin dual therapy matches quadruple efficacy with fewer adverse events
Tegoprazan dual therapy matches standard H. pylori treatment
This systematic review and meta-analysis with trial sequential analysis compared tegoprazan-amoxicillin (TA) dual therapy with bismuth-conta…
A new review finds a simpler two-drug H. pylori treatment works as well as standard therapy, with fewer side effects.
Vonoprazan-amoxicillin dual therapy is a safe alternative to bismuth-containing quadruple therapy for H. pylori
New vonoprazan treatments show promise for clearing H. pylori infection
This multicenter randomized controlled trial of 579 H. pylori-positive patients found that vonoprazan-amoxicillin (VA) dual therapy demonstr…
Two new simplified drug combinations could offer a simpler way to clear H. pylori infections, especially for patients with certain allergies…
Antibiotic resistance mutations drive H. pylori treatment failure across Asia-Pacific region
Antibiotic resistance in H. pylori rising across Asia
This meta-analysis of H. pylori infections in the Asia-Pacific region finds that clarithromycin resistance (19-34%) is driven by A2142G/A214…
H. pylori bacteria in Asia are increasingly resistant to common antibiotics, driven by specific mutations.
Pooled Salmonella prevalence in Ethiopia is 6.7% with significant regional and source variations
Tracking Salmonella Bacteria and Drug Resistance Across Different Areas of Ethiopia
This meta-analysis of 43 datasets from 39 articles identifies a pooled Salmonella prevalence of 6.7% (95% CI: 5.3-8.1%) across human, animal…
New data shows how common Salmonella is in people, animals, and the environment while tracking how well it resists common medicines.
Meta-analysis finds no clear difference between amoxicillin and other antibiotics for community-acquired pneumonia
Doctors find amoxicillin works just as well as other drugs for pneumonia
A systematic review and meta-analysis compared amoxicillin and amoxicillin-clavulanate to other antibiotics for community-acquired pneumonia…
New research shows a common antibiotic called amoxicillin works just as well as other options for treating pneumonia in people of all ages.
Retrospective study compares antibiotic regimens for H. pylori eradication in children
Two antibiotic regimens cleared H. pylori in most children within four weeks
This retrospective observational study evaluated two antibiotic combinations for treating Helicobacter pylori infection in children aged 4 t…
A look at two common treatments found that both regimens successfully eliminated the bacteria in most children within four weeks.
Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children
New Mix Clears Stomach Bugs Better in Children
This retrospective cohort study of 161 pediatric patients compared 14-day bismuth-containing quadruple therapy against triple therapy for He…
A four-drug plan works better than the usual three-drug plan for clearing stomach bacteria in kids.
H. pylori eradication reduces cholesterol and LDL in patients with cardiovascular disease risk
Treating This Stomach Bug May Quietly Lower Heart Risk
A randomized controlled trial in 72 patients with H.
Treating a common stomach infection can lower cholesterol and small dense lipoprotein particles a year later, potentially reducing heart dis…
Meta-analysis finds vonoprazan-based therapies achieve 94% H. pylori eradication in Asian populations
The Two-Drug Combo Clearing Stomach Bacteria Where Others Are Failing
A systematic review and meta-analysis of 7,498 Asian patients with Helicobacter pylori infection compared vonoprazan-amoxicillin regimens to…
A new two-drug combo clears stomach bacteria in 94% of Asian patients, outperforming standard treatments where others are failing.
Cross-sectional study finds high antibiotic use for productive cough in Kenyan clinic patients
Your Cough Could Be Fueling a Global Health Crisis. Here’s How
A cross-sectional study of 400 adults with productive cough attending chest and tuberculosis clinics in Nairobi found 86.7% used antibiotics…
The way people access common antibiotics for a cough is often informal and risky, creating a direct path for deadly, drug-resistant infectio…
All amoxicillin Articles
- Keverprazan-amoxicillin dual therapy shows non-inferior H. pylori eradication versus esomeprazole-amoxicillin
- Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children
- Tegoprazan-amoxicillin dual therapy matches quadruple efficacy with fewer adverse events
- Vonoprazan-amoxicillin dual therapy is a safe alternative to bismuth-containing quadruple therapy for H. pylori
- Antibiotic resistance mutations drive H. pylori treatment failure across Asia-Pacific region
- Pooled Salmonella prevalence in Ethiopia is 6.7% with significant regional and source variations
- Meta-analysis finds no clear difference between amoxicillin and other antibiotics for community-acquired pneumonia
- Retrospective study compares antibiotic regimens for H. pylori eradication in children
- Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children
- H. pylori eradication reduces cholesterol and LDL in patients with cardiovascular disease risk
- Meta-analysis finds vonoprazan-based therapies achieve 94% H. pylori eradication in Asian populations
- Cross-sectional study finds high antibiotic use for productive cough in Kenyan clinic patients
- Systematic review finds limited evidence for antibiotics in low back pain with Modic changes
- Vonoprazan-based regimens show higher H. pylori eradication rates than rabeprazole dual therapy in Chinese cohort
- Adjunctive antibiotics in peri-implantitis surgery reduce bleeding on probing but not other outcomes